Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cutaneous polyarteritis nodosa (CPAN) is a rare limited form of polyarteritis nodosa (PAN), characterized by cutaneous vasculitis and mild and transient extracutaneous manifestations such as mild arthralgia, arthritis,myalgia, and rarely peripheral neuropathy.
Biomarker and diagnostic research for cutaneous polyarteritis nodosa has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include drug therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
22 publications have been identified in PubMed for cutaneous polyarteritis nodosa. Research spans Case Report / Case Series (55%), Epidemiology / Natural History (14%), and Review / Meta-Analysis (9%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 12 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 9:38 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression | 3 | 14% |
Research summaries | 2 | 9% |
Clinical study results | 2 | 9% |
Testing and diagnosis research | 1 | 5% |
Laboratory research | 1 | 5% |
New treatment approaches | 1 | 5% |
Stanton M (2026). [PMID: 29489258](https://pubmed.ncbi.nlm.nih.gov/29489258/). *Unknown Journal*. [Review / Meta-Analysis]
Cottu A (2026). [PMID: 41369608](https://pubmed.ncbi.nlm.nih.gov/41369608/). *Journal of the American Academy of Dermatology*. [Gene Therapy / Novel Therapeutics]
Zangenah N (2026). [PMID: 41276121](https://pubmed.ncbi.nlm.nih.gov/41276121/). *Journal of the American Academy of Dermatology*. [Epidemiology / Natural History]
Fukai R (2025). [PMID: 41277663](https://pubmed.ncbi.nlm.nih.gov/41277663/). *European journal of dermatology : EJD*. [Case Report / Case Series]
Hirano T (2025). [PMID: 40488339](https://pubmed.ncbi.nlm.nih.gov/40488339/). *International journal of dermatology*. [Case Report / Case Series]
Melloy MP (2025). [PMID: 40433812](https://pubmed.ncbi.nlm.nih.gov/40433812/). *Pediatric dermatology*. [Case Report / Case Series]
Howell EA (2025). [PMID: 40601885](https://pubmed.ncbi.nlm.nih.gov/40601885/). *Neurology*. [Clinical Trial Publication]
Okubo N (2025). [PMID: 39673763](https://pubmed.ncbi.nlm.nih.gov/39673763/). *Modern rheumatology case reports*. [Case Report / Case Series]
Boughaleb S (2025). [PMID: 40416221](https://pubmed.ncbi.nlm.nih.gov/40416221/). *Cureus*. [Case Report / Case Series]
Harama K (2025). [PMID: 40374513](https://pubmed.ncbi.nlm.nih.gov/40374513/). *The Journal of rheumatology*. [Case Report / Case Series]